RedHill Biopharma anuncia datos positivos de seguridad y eficacia del estudio de COVID-19 de fase 2 de Opaganib ...Middle East

Los datos preliminares del estudio en Fase 2 de Estados Unidos de 40 pacientes hospitalizados muestran que opaganib administrado por vía oral era seguro, sin diferencias materiales de seguridad entre opaganib y los brazos de control Las tendencias consistentes demuestran una mayor mejora...

Hence then, the article about redhill biopharma anuncia datos positivos de seguridad y eficacia del estudio de covid 19 de fase 2 de opaganib was published today ( Monday 04/01/2021 - 09:45 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( RedHill Biopharma anuncia datos positivos de seguridad y eficacia del estudio de COVID-19 de fase 2 de Opaganib )

Also on site :

• Macy’s Valley Fair shoppers thwart Rolex watch thieves
• RCB-W vs UPW-W Dream11 Prediction, Dream11 Playing XI, Today Match 5, WPL 2026
• Motional puts AI at center of robotaxi reboot as it targets 2026 for driverless service